Synapse - Department of Medicine

Results (39721)

EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma

Journal Article

Rosenberg, J. E.; Powles, T.; Sonpavde, G. P.; Loriot, Y.; Duran, I.; Lee, J. L.; Matsubara, N.; Vulsteke, C.; Castellano, D.; Mamtani, R.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up☆

Guidelines

Conroy, T.; Pfeiffer, P.; Vilgrain, V.; Lamarca, A.; Seufferlein, T.; O'Reilly, E. M.; Hackert, T.; Golan, T.; Prager, G.; Haustermans, K.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: An ACCENT/IDEA pooled analysis of seven trials

Journal Article

Taieb, J.; Sinicrope, F. A.; Pederson, L.; Lonardi, S.; Alberts, S. R.; George, T. J.; Yothers, G.; Van Cutsem, E.; Saltz, L.; Ogino, S.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer

Journal Article

Jhaveri, K.; O’Shaughnessy, J.; Fasching, P. A.; Tolaney, S. M.; Yardley, D. A.; Sharma, V. K.; Biswas, C.; Thuerigen, A.; Pathak, P.; Rugo, H. S.
Therapeutic Advances in Medical Oncology (2023)

Fulltext@MSK | Save

A quantitative multiparametric MRI analysis platform for estimation of robust imaging biomarkers in clinical oncology

Journal Article

LoCastro, E.; Paudyal, R.; Konar, A. S.; LaViolette, P. S.; Akin, O.; Hatzoglou, V.; Goh, A. C.; Bochner, B. H.; Rosenberg, J.; Wong, R. J.; more...
Tomography (2023)

Fulltext@MSK | Save

IL12/23 blockade with ustekinumab as a treatment for immune-related cutaneous adverse events

Journal Article

Gu, S. L.; Maier, T.; Moy, A. P.; Dusza, S.; Faleck, D. M.; Shah, N. J.; Lacouture, M. E.
Pharmaceuticals (2023)

Fulltext@MSK | Save

Safety of immunomodulatory systemic therapies used in the management of immune-related cutaneous adverse events

Review

Gu, S. L.; Nath, S.; Markova, A.
Pharmaceuticals (2023)

Fulltext@MSK | Save

Patient and clinician stakeholder perspectives on a patient portal questionnaire eliciting illness and treatment understanding and core health-related values

Journal Article

Rosa, W. E.; Gilliland, J.; McDarby, M.; Nelson, J. E.; Desai, A. V.; Epstein, A. S.
Palliative Medicine Reports (2023)

Fulltext@MSK | Save

Exocrine pancreatic insufficiency induced by immune checkpoint inhibitors

Journal Article

Satish, D.; Lin, I. H.; Flory, J.; Gerdes, H.; Postow, M. A.; Faleck, D. M.
The Oncologist (2023)

Fulltext@MSK | Save

Phase Ib/II study of the efficacy and safety of binimetinib (MEK162) plus panitumumab for mutant or wild-type RAS metastatic colorectal cancer

Journal Article

Van Cutsem, E.; Yaeger, R.; Delord, J. P.; Tabernero, J.; Siu, L. L.; Ducreux, M.; Siena, S.; Elez, E.; Kasper, S.; Zander, T.; more...
The Oncologist (2023)

Fulltext@MSK | Save